Die Magnetresonanztomographie des Herzens (kardiale Resonanztomographie, MRT) ist ein bildgebendes, strahlenfreies Verfahren, welche als Goldstandard für die Beurteilung der Herzanatomie, -funktion und sogar der Gewebezusammensetzung gilt. Die RESILIENCE-Studie wird das Verfahren der MRT als Hauptergebnismessmethodik verwenden, und die in der Studie eingeschlossenen Patienten erhalten jeweils drei MRT-Untersuchungen im Rahmen der Teilnahme an der Studie.
Multinationale, prospektive, doppelverblindete, scheinkontrollierte, randomisierte, klinische Phase 2 proof-of-concept-Studie zur Bewertung der Wirksamkeit und Sicherheit der ferngesteuerten-ischämischen Konditionierung (RIC) bei Patienten mit einem Lymphom (NHL), die Anthrazykline erhalten. Patienten, für die ≥5 Chemotherapiezyklen geplant sind, kommen für die Studienteilnahme in Frage.
The European Society of Cardiology (ESC) through the ESC Council of Cardio-Oncology will host on October 19th the first multi-stakeholder meeting in the context the RESILIENCE project, funded by the European Commission, to share the latest results with different stakeholders and patients. The event will focus on emerging therapies for
RESILIENCE Project will participate on Friday, September 29th in the XIV European Researchers Night in Madrid with an activity in which the public of all ages can attend, free of charge, with prior registration. The “RESILIENCE Workshop and laboratory visit. Surviving cancer with a strong heart” where we will have
The RESILIENCE trial has expanded its inclusion criteria to allow more types of lymphoma to be included in the trial. These changes are proposed after having agreed with the recruiting hospitals. To date, only patients with a specific type of lymphoma (non-Hodgkin) were included, but after a careful study by
On Friday June 16th we made the initial visit at the San Carlos Clinical Hospital in Madrid and it is with great pleasure that we welcome this Hospital to our RESILIENCE project, in which we work hard every day to help people survive cancer with a strong heart. During the
On Thursday June 1st Hospital Universitario 12 de Octubre in Madrid has joined the RESILIENCE project and it will most probably begin to recruit patients in the coming weeks. Hospital 12 de Octubre obtained in 2020 the Best in Class (BIC) Award for the Best Service in Hematology and Hemotherapy, the
On Friday May 12th our RESILIENCE Steering Committee and General Assembly session were held at the National Center for Cardiovascular Research (CNIC) in Madrid. The meetings counted on the support of all the partners of the project financed by the European Commission, both national and international, as well as members
